Drug intelligence / Profile preview

colloidal oat + glycerin

Development stage
Unknown
Lead developer
Johnson & Johnson
Modality
Small Molecules
Administration
Topical
01

Overview

Colloidal oat + glycerin is a topical emollient combination used for skin barrier protection and the prevention of atopic dermatitis, particularly in high-risk infants. Colloidal oatmeal (Avena sativa) provides a complex mixture of polysaccharides, lipids, and proteins that form a protective film on the skin, while its avenanthramide components exert anti-inflammatory and antioxidant effects. Glycerin acts as a potent humectant, attracting and retaining moisture in the stratum corneum to improve skin hydration and elasticity. Clinical data from the STOP AD trial indicates that early, short-term use of this combination can modulate the infant skin microbiome, promoting the abundance of taxa associated with a lower risk of developing atopic dermatitis.

Brand names
Aveeno
Other names
colloidal oatmeal + glycerincolloidal oatmeal and glycerin
02

Targets

NF-κBIL8 (C-X-C Motif Chemokine Ligand 8)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on colloidal oat + glycerin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on colloidal oat + glycerin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call